Cell Source, Inc.

CLCS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $195.2K

Liabilities Breakdown FY2023

Total Liabilities: $15.8M